Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

LONZA Biologics plc

Lonza is continually expanding its scientific and technology base, assigning a high priority to advanced R&D as well as state-of the-art plants and equipment to ensure environmentally safe and quality-minded production. Creative thinking, dedicated staff and sound resources are the strengths that Lonza relies on for further growth. Our people are the key to success – they have extensive expertise in multidisciplinary project management, integrating the wishes and know-how of our customers at every stage.


Contact Details:
228 Bath Road
Slough
Berkshire
SL1 4DX
United Kingdom
Tel:44 1753 777000
Fax:44 1753 777001
Email:contact.slough@lonza.com
WWW:

www.lonza.co.uk/




Loading...

Recent Publications by LONZA Biologics plc:

Process analytics for purification of monoclonal antibodies.
The application of appropriate analytical methods is an essential...
22nd May, 2007
Lonza Biologics Plc, 228 Bath Road, Slough, Berkshire SL1 4DX, UK. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 15;848(1):79-87.
DOI Direct Link
Antibody production.
The clinical and commercial success of monoclonal antibodies has led to...
20th October, 2006
Lonza Biologics plc, 228 Bath Road, Slough, Berkshire, SL1 4DX, UK. Adv Drug Deliv Rev. 2006 Aug 7;58(5-6):671-85. Epub 2006 May 22.
DOI Direct Link
Biopharmaceutical proteins: opportunities and challenges.
The clinical and commercial success of monoclonal antibodies has led to...
13th September, 2005
Lonza Biologics plc, Slough, UK. Methods Mol Biol. 2005;308:1-16.
DOI Direct Link
On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells.
Monoclonal antibodies (Mab) are heterotetramers consisting of an equimolar...
8th July, 2005
School of Engineering, University of Queensland, QLD 4072, Australia, and Biotechnol Prog. 2005 Jan-Feb;21(1):122-33.
DOI Direct Link

LONZA Biologics plc Patents:

US Patent No.Title
7439037 Use of aminoglycoside resistance gene
7258998 Cell culture medium

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1933 times since April 2007, the link to the organisation's website has been followed 349 times

Recent Search Terms used to find this page: lonza biologics slough | Lonza Biologics plc | lonza biologics plc | Lonza Biologics UK | Lonza Biologics PLC | Lonza Biologics plc | Lonza Biologics PLC | lonza biologics slough | lonza biologics uk | lonza biologics plc | .

Search for more companies in Slough

Search for more companies in Berkshire



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for LONZA Biologics plc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.